Aandelen in “Fabricage van farmaceutische preparaten”

Aandeel Datum Koers Evolutie
vlag Qualigen Therapeutics Inc 20/05 0,295 USD
+0,65% 		+0,65%
vlag Quotient Ltd 13/05 0,380 USD
0,00% 		0,00%

Nieuws over “Fabricage van farmaceutische preparaten”

22:54 · Sanofi: Information concerning the total number of voting rights and shares - April 2024 · Persbericht

22:54 · Sanofi: Information concerning the total number of voting rights and shares - April 2024 · Persbericht

22:28 · Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Conference Plenary Session · Persbericht

20:15 · Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM · Persbericht

14:30 · Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine · Persbericht

13:30 · Soligenix Encourages Stockholders to Vote Prior to Annual Meeting · Persbericht

13:00 · PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation · Persbericht

17/05 · BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification · Persbericht

17/05 · AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week® · Persbericht

17/05 · Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules · Persbericht

17/05 · AKRO Investors: Reminder - Important Deadline in Securities Fraud Class Action Lawsuit Akero Therapeutics, Inc. · Persbericht

16/05 · Galapagos creates new subscription right plans · Persbericht

16/05 · Galapagos creëert nieuwe inschrijvingsrechtenplannen · Persbericht

16/05 · Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress · Persbericht

16/05 · Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer · Persbericht

16/05 · Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis · Persbericht

16/05 · Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice · Persbericht

16/05 · Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte · Persbericht

16/05 · Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome · Persbericht

16/05 · With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin · Persbericht

15/05 · Galapagos gaat kankertherapie produceren in Amerikaanse bloedcentra · Tijd.be (€)

Het beursgenoteerde Mechelse biotechbedrijf Galapagos gaat samenwerken met Blood Centers of America, het grootste Amerikaanse bloedvoorzieningsnetwerk, om er lokaal zijn gepersonaliseerde kankerbehand...

Mijn selecties